<?xml version="1.0" encoding="UTF-8"?>
<p>Individual fungal diseases have profound impacts on human health. Around 220,000 new cases of cryptococcal meningitis occur worldwide each year, resulting in 181,000 deaths concentrated in sub-Saharan Africa [
 <xref rid="pntd.0007964.ref013" ref-type="bibr">13</xref>]. More than 400,000 people develop 
 <italic>Pneumocystis</italic> pneumonia annually and die without access to therapy [
 <xref rid="pntd.0007964.ref011" ref-type="bibr">11</xref>]. In Latin America, histoplasmosis is one of the most common opportunistic infections among people living with HIV/AIDS, and approximately 30% of patients diagnosed with histoplasmosis in that region die from this disease [
 <xref rid="pntd.0007964.ref012" ref-type="bibr">12</xref>]. Morbidity rates linked to fungal infections also represent an important health issue. For example, diseases such as chromoblastomycosis and eumycetoma lead to destructive deformations and debilitating conditions of the subcutaneous tissues, skin, and underlying bones, which result in social exclusion [
 <xref rid="pntd.0007964.ref014" ref-type="bibr">14</xref>].
</p>
